Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Table 12: Results at Week 26 in a Trial Comparing TRESIBA at Same and Alternating Times to Insulin Glargine U -100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* Study H TRESIBA Administered at the Same Time Each Day in Combination with a Rapid Acting Insulin Analog at Mealtimes in Adult Patients The efficacy of TRESIBA was evaluated in a 52 week randomized, open label, multicenter trial in 992 patients with type 2 diabetes mellitus inadequately controlled on premix insulin, bolus insulin alone, basal insulin alone, oral antidiabetic agents (OADs) alone or any combination thereof
World Clin
They play a critical role in regulating numerous bodily functions, including metabolism, immune system responses, and neurotransmitter activity
It also lowers the risk of gallstones
US$ 26.12
US$ 23.55
US$ 23.27
